Dr MP Gowrav Assistant Professor JSS College of Pharmacy SS Nagar Mysuru570015 Contents Introduction Definition Why GMP Evolution of GMP Principles of GMP WHO GMP USFDA cGMP European Medicines agency GMP ID: 904633
Download The PPT/PDF document "Concept of GMP & cGMP" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Concept of GMP & cGMP
Dr. M.P.
Gowrav
Assistant Professor
JSS College of Pharmacy
S.S. Nagar, Mysuru-570015
Slide2Contents
Introduction
Definition
Why GMPEvolution of GMPPrinciples of GMPWHO GMPUSFDA cGMPEuropean Medicines agency GMPPICsIndian GMPCFRHistory of CFRCFR Title 21References
2
Slide3Students should be able toUnderstand the concept of GMP &
cGMP
Understand WHO GMP, EMA GMP & US
cGMPKnow the history of CFR & Parts of CFR3Learning outcomes
Slide4DEFINITION:GMP is that part of Quality Assurance which ensures that products are consistently produced and controlled to the quality standard appropriate to their intended use and as required by the marketing authorization.
Good Manufacturing Practices (GMPs) are regulations that describe the methods, equipment, facilities, and controls required for producing:
Human
and veterinary productsMedical devicesProcessed food4Introduction
Slide5Usually see “cGMP” – where c = current, to emphasize that the expectations are dynamic. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.
These regulations, which have the force of law, require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood take protective steps to ensure that their products are safe,
pure and effective.
Require a quality approach to manufacturing, enabling companies to minimize or eliminate instances of contamination, mix-ups and errors. Protects the consumer from purchasing a product, which is not effective or even dangerous. GMP regulations address issues including record keeping, personnel qualifications, sanitation, cleanliness, equipment verification, process validation, and complaint handling. In short GMP makes the difference between nearly right and exactly right.5Introduction
Slide6Final testing of the product cannot ensure the Quality efficiency and safety.Final testing may always not detect contamination, error, etc.
Conformance
to the predetermined specification.
To minimize contamination eg:- microbial contamination.To eliminate error.To produce product of consistent quality.Government requirement. Ensure quality product. Reduce rejects, recalls. Satisfied customers. Company image and reputation. 6Why GMP?
Slide71963: - first GMP publication –USA1971: -first revision1978: - Major revision
Current
regulation of GMP appear in part 210 (title 21) of code of federal regulations published by USFDA
7EVOLUTION OF GMP
Slide8Unexpected contamination of products, causing damage to health or even death.Incorrect labels on containers, which could mean that patients receive the wrong medicine.Insufficient
or too much active ingredient, resulting in ineffective treatment or adverse effects.
8
MAIN RISKS WITHOUT GMP
Slide9Design and construct the facilities and equipments properlyFollow written procedures and Instructions
Document
work
Validate workMonitor facilities and equipmentWrite step by step operating procedures and work on instructionsDesign ,develop and demonstrate job competenceProtect against contaminationControl components and product related processesConduct planned and periodic audits9PRINCIPLES OF GMP
Slide10WHO GMP requirements, norms and standards are useful for acceptance of product applications through the prequalification process for participation in global procurement programmesThese serve as reference guidance for national medicines regulatory authorities to enforce
Most NMRAs from developing countries follow the WHO GMP guidelines
WHO guidelines on GMP are contained in:
TRS 986Annex 3 TRS 822 (Biological products)Annex 4 TRS 937 (Validation & QA)Annex 5 TRS 961 (non-sterile products)Annex 6 (Sterile [pharmaceutical products- under revision to consolidate EU, PIC/S & WHO)Appendix 7, Annex 3 TRS 932 (validation of sterile products) Annex 7 TRS 908 (risk analysis application of Hazard analysis and critical control point)Annex 7 TRS 961 (transfer of technology)10WHO Good Manufacturing Practices
Slide11cGMP refers to the Current Good Manufacturing Practices that are enforced by the US FDAThe US FDA governs
cGMP
through Code of Federal Regulations (CFR: title 21 (parts 1-1499)
CFRs have a legal binding force under Title 21 which interprets the Federal Food, Drug and Cosmetics Act and related statutes, including Public Health Service ActThe regulations enable a common understanding of the regulatory process by describing the requirements to be followed by drug manufacturers, applicants, and FDA21 CFR Part 314 - For FDA approval to market a new drug21 CFR Part 210 - Current Good Manufacturing Practice in Manufacturing Processing, packing, or Holding of Drugs21 CFR Part 211 - Current Good Manufacturing Practice for Finished Pharmaceuticals21 CFR Part 212 - Current Good Manufacturing Practice for Positron Emission Tomography Drugs21 CFR Part 600 - Biological Products11US Food and Drug Administration cGMP
Slide12European medicines Agency (EMA) co-ordinates GMP and has a pivotal role in harmonization of GMP activities within European Union (EU)GMP mandate in EMA is enforced through regulations, directives and guides (provided under
Eudralex
)
Currently, regulation No. 1252/2014 (APIs) and directives 2003/94/EC (human medicines) and 91/412/EEC (veterinary medicines) applyRegulations have binding legal force in every Member State and enter into force on a defined date while directives lay down outcomes that must be achieved; therefore, each member state may have independent interpretation when transposing into national lawsEMA is only responsible for products authorized through the centralized procedure while Competent national authorities are responsible for products authorized at national level12European Medicines Agency GMP
Slide13The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is a non-binding, informal co-operative arrangement between Regulatory Authorities in the field of Good Manufacturing Practice (GMP) of medicinal products for human or veterinary useIt is open to any Authority having a comparable GMP inspection system
Currently has 52 active members, including US FDA, Health Canada's Regulatory Operations and Enforcement Branch, the South African Health Products Regulatory Authority, and several regulatory agencies of countries in Europe, Asia, the Middle East and the Americas
The PIC/S GMPs are equivalent to the EU GMP guidelines in terms of GMP requirements.
13Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Slide14Indian GMP regulations are underpinned by the Drugs and Cosmetics Act, 1940 under Rules 1945 (Schedule M)These are to be interpreted with many other conditions laid down under various rulesSchedule M covers all aspects of production from the raw materials, premises and equipment to the training and personnel
hygiene.
14
Indian GMP
Slide15What is CFR ?The Code of Federal Regulations (CFR) is the codification of the general and permanent rules and regulations (sometimes called administrative law) published in the Federal Register by the executive departments and agencies of the federal
government
of the United States
.The CFR is divided into 50 titles that represent broad areassubject to federal regulation.15CODE OF FEDERAL REGULATIONS (CFR)
Slide16Each title is further divided into chapters, subchapters, parts, and sections.A regulation is cited by title, part, and section, e.g. 14
CFR 121.313
(Title 14, Part 121, Section 313
).The soft-cover volumes of the CFR are issued each year :Titles 1 – 16 are updated as of January 1Titles 17 – 27 are updated as of April 1Titles 29 – 41 are updated as of July 1Titles 42 – 50 are updated as of October 116CODE OF FEDERAL REGULATIONS (CFR)
Slide17The online CFR is a joint project authorized by the publisher, the National Archives and Records Administration's (NARA) Office of the Federal Register (OFR), and the
Government Publishing
Office (GPO) to provide the public with
enhanced access to Government information.17CODE OF FEDERAL REGULATIONS (CFR)
Slide18Franklin D. Roosevelt – 32nd President of the US.1935 - Instrumental in passing the Federal Register Act – empowered the National
Archives of
the US to form an Administrative Committee
– publish the Federal Register.The Federal Register Act - amended in 1937 to provide a “codification” of all regulations every five years – known as Code of Federal Regulations.18HISTORY OF CFR
Slide19The first edition of the CFR was published in 1938 and included all finalized regulations that were published in the Federal Register from March 14, 1936 to June 1, 1938 Beginning in 1963 for some titles and for all titles in 1967, the Office of the Federal Register began publishing yearly revisions.
Beginning
in 1972 - published revisions were conducted in staggered quarters
.19HISTORY OF CFR
Slide20Title 21 of the CFR is reserved for rules of the Food and Drug Administration.Governs food and drugs within the United States
for the
FDA, DEA, and the ONDCP.
In all, 21 CFR consists of 1499 parts.It is divided into three chapters:Chapter I — Food and Drug AdministrationChapter II — Drug Enforcement AdministrationChapter III — Office of National Drug Control Policy20CFR TITLE 21
Slide21Most of the Chapter I regulations are based on the Federal Food, Drug, and Cosmetic Act.Notable sections:
– 11 Electronic records and electronic signature related.
– 50 Protection of human subjects in clinical trials.
– 54 Financial Disclosure by Clinical Investigators.– 56 Institutional Review Boards that oversee clinical trials.– 58 Good Laboratory Practices (GLP) for nonclinical studies.21CHAPTER I
Slide22The 100 series are regulations pertaining to food.The 200 and 300 series are regulations pertaining to pharmaceuticals
The
500 series are regulations for animal
feeds and animal medications.The 600 series covers biological products.The 700 series includes the limited regulations on cosmetics.The 800 series are for medical devices.22CHAPTER I
Slide23The 900 series covers mammography quality requirements enforced by CDRH.The 1000 series covers radiation-emitting device
The
1100 series includes updated rules with regards
to tobacco products.The 1200 series consists of rules primarily based in laws other than the Food, Drug, and Cosmetic Act:– Requirements for pasteurization of milk.– Sanitation on interstate conveyances.23
Slide24Notable sections:– 1308 — Schedules of controlled substances1308.03(a) — Administrative Controlled Substances
Code Number
1308.11
— List of Schedule I drugs1308.12 — List of Schedule II drugs1308.13 — List of Schedule III drugs1308.14 — List of Schedule IV drugs1308.15 — List of Schedule V drugs24CHAPTER II
Slide25The list of SCHEDULED DRUGS, as a part of the Controlled Substances Act, falls under the drug policy of the United States government. The following findings are required
for drugs
to be placed in the aforementioned schedules:
– The drug or other substance has a high potential for abuse.– The drug or other substance has no currently accepted medical use in treatment in the United States.– There is a lack of accepted safety for use of the drug or other substance under medical supervision.Administrative Controlled Substances Code Number (ACSCN)25
Slide26There are a number of electronic sources for accessing CFR. For instance - FDsys.gov and the now GovInfo
, the
official online
document repository for the U.S. Government Publishing Office, is fully browsable, searchable, navigable by citation.GPO also maintains an up-to-date “Electronic Code of Federal Regulations (e-CFR)” service which presents CFR sections in their current form with any recent amendments from the Federal Register already incorporated. The e-CFR service is updated daily and also allows you to separately view appendices and supplements.26CFR in Modern Times
Slide27TABLE OF CONTENTS –– CFR titles are broken down by chapter, subchapter, and part
.
– Immediately preceding each part is a table of contents
for the individual regulations contained within that part .TABLE OF CFR TITLES AND CHAPTERS –– Redesignation tables to help trace new location of parts and sections of A regulationLIST OF CFR SECTIONS AFFECTED IN THE VOLUME –– List of CFR Sect ions Affected in Each Volume indicates the Type of Change that was made.27Research Tools in CFR
Slide28The Federal Register and the Code of Federal Regulations replaced the existing system of dual set of regulations and legislations that were in place. Although not perfect, the Federal Register and the CFR appear to have met their original purpose of providing the public with a comprehensive publication vehicle for all the regulations issued by Federal agencies and the President.
The
CFR provided a codified form of the regulations, based on title, chapters and subjects, that streamlined the process of finding the required regulations and laws for the pharmaceutical industry and the public in general, thereby making these guidelines easily accessible
28Key Points (Summary)
Slide29References
FDA: Current Good manufacturing Practices (
cGMP
regulations) (accessed: https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations) EMA: Good manufacturing Practice (accessed: https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice#legal-framework-and-guidance-sectionMcgee Pharma International (Nov. 2016): EU and US GMP/GDP: Similarities and Differences WHO (2014): Good manufacturing practices for pharmaceutical products: main principles In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-eighth report. Geneva, World Health Organization (WHO Technical Report Series, No. 986), Annex 2. Uma Vasireddy (2015) 4th International Summit on GMP, GCP and Quality control: Comparison of guidelines of Indian GMP with WHO GMP (accessed: https://gmp-gcp-qualitycontrol.pharmaceuticalconferences.com/abstract/2015/comparison-of-guid elines-of-indian-gmp-with-who-gmp) India GMP: Schedule M (Part 1): Good manufacturing practices and requirements of premises, plant and equipment for pharmaceutical products.
http
://
www.llsdc.org/fr-cfr-research-guide
Panama
Refining Co. v. Ryan, 293 U.S. 388 (1935). Available
from: https
://supreme.justia.com/cases/federal/us/293/388/case.html
Griswold
, E.N. Government in ignorance of the law; a plea for
better publication
of executive legislation. 48
Harv
. L. Rev. 198-215 (1934
). Available from: https
://public.resource.org/48HarvLRev198.pdf
CFR
- Code of Federal Regulations Title 21. Available from
:https
://
www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm (Accessed
on 13th
July 2020)
https
://
en.wikipedia.org/wiki/Title_21_of_the_Code_of_Federal_Regulations
29
Slide30Thank
You
30